"10.1371_journal.pone.0055818","plos one","2013-01-31T00:00:00Z","Lisa Christiansson; Stina Söderlund; Emma Svensson; Satu Mustjoki; Mats Bengtsson; Bengt Simonsson; Ulla Olsson-Strömberg; Angelica S I Loskog","Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Department of Medical Sciences, Uppsala University and Department of Hematology, University Hospital, Uppsala, Sweden; Hematology Research Unit Helsinki, Department of Medicine, Division of Hematology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland; Section of Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, Uppsala, Sweden","Revised the manuscript critically for important intellectual content: ES SM MB BS UO-S. Conceived and designed the experiments: LC SS SM MB BS UO-S AL. Performed the experiments: LC SS ES SM. Analyzed the data: LC SS SM AL. Contributed reagents/materials/analysis tools: SM MB UO-S. Wrote the paper: LC SS AL.","Satu Mustjoki receives honoraria from Novartis and Bristol-Myers Squibb, Angelica Loskog is the CEO of Lokon Pharma AB, a scientific advisor to NEXTTOBE AB and has a royalty agreement with Alligator Biosciences AB. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Lisa Christiansson","LC",8,TRUE,7,4,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
